Vanderbilt Amyloid Multidisciplinary Program | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
Vanderbilt Amyloid Multidisciplinary Program

Vanderbilt Amyloid Multidisciplinary Program

1211 Medical Center Drive
Nashville, Tennessee, United States
Phone   Web  

Vanderbilt Amyloid Multidisciplinary Program is focused on providing complete care for amyloidosis patients. Amyloidosis is a rare disease and can affect multiple organs. The team works with other clinical departments to ensure that patients receive the best care possible. 

Treatment Options provided:

• Stem cell transplant (Stem cell transplants are also used to treat cancer, but amyloidosis is not a cancerous disease.)

• Organ transplant

Since amyloidosis can affect multiple organs, you may have appointments in various clinics at Vanderbilt. You can rest assured that you will have your appointments in at least 2 days if you have to visit various clinics.

If you are traveling to Vanderbilt and do not live in the Nashville area, we can help you with lodging and transportation during your stay.

The team includes healthcare professionals in the following areas:

Hematology and Oncology:
Stacey A. Goodman, MD

Nephrology:
Anthony J. Langone, MD

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close